Adagene Inc. (ADAG)
NASDAQ: ADAG · Real-Time Price · USD
2.850
-0.090 (-3.06%)
At close: Feb 3, 2026, 4:00 PM EST
2.950
+0.100 (3.51%)
After-hours: Feb 3, 2026, 4:10 PM EST
Adagene Market Cap
Adagene has a market cap or net worth of $139.04 million as of February 3, 2026. Its market cap has increased by 70.69% in one year.
Market Cap
139.04M
Enterprise Value
83.06M
1-Year Change
70.69%
Ranking
Category
Stock Price
$2.85
Market Cap Chart
Since the IPO on February 9, 2021, Adagene's market cap has decreased from $804.22M to $139.04M, a decrease of -82.71%. That is a compound annual growth rate of -29.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 138.57M | 55.56% |
| Dec 31, 2025 | 89.08M | 1.11% |
| Dec 31, 2024 | 88.10M | 4.06% |
| Dec 29, 2023 | 84.66M | 47.15% |
| Dec 30, 2022 | 57.54M | -83.64% |
| Dec 31, 2021 | 351.59M | -56.28% |
| Feb 9, 2021 | 804.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rani Therapeutics Holdings | 145.83M |
| Black Diamond Therapeutics | 144.72M |
| Fate Therapeutics | 141.88M |
| Elicio Therapeutics | 141.55M |
| Cibus | 140.52M |
| Connect Biopharma Holdings | 139.20M |
| Unicycive Therapeutics | 138.62M |
| Seres Therapeutics | 137.05M |